España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ProKidney
PROK
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.69
-0.05
-2.87%
At close: -
$1.71
0.02
1.18%
After Hours: Nov 22, 7:24 PM EDT
Get Report
Comment
ProKidney (PROK) Forecast
News
Earnings
ProKidney (PROK) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ProKidney (NASDAQ:PROK) Stock
ProKidney Stock (NASDAQ: PROK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 12, 2024
ProKidney Q3 2024 GAAP EPS $(0.14) Beats $(0....
Benzinga Newsdesk
Monday, October 14, 2024
ProKidney to Present Cell Therapy Data for CK...
Benzinga Newsdesk
Monday, September 30, 2024
JP Morgan Initiates Coverage On ProKidney wit...
Benzinga Newsdesk
Tuesday, September 10, 2024
ProKidney shares are trading higher after Gug...
Benzinga Newsdesk
Guggenheim Initiates Coverage On ProKidney wi...
Benzinga Newsdesk
Wednesday, September 04, 2024
B of A Securities Maintains Neutral on ProKid...
Benzinga Newsdesk
Tuesday, September 03, 2024
ProKidney Decides To Prioritize PROACT 1; Pla...
Benzinga Newsdesk
Friday, August 09, 2024
ProKidney Q2 EPS $(0.16) Beats $(0.17) Estima...
Benzinga Newsdesk
Wednesday, June 26, 2024
Over $30M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
Avi Kapoor
Friday, June 21, 2024
Play Likely Earnings Beat With 3 Top-Ranked Stocks
Zacks
Wednesday, June 12, 2024
Reported Earlier, ProKidney Prices Upsized $1...
Benzinga Newsdesk
Tuesday, June 11, 2024
Why Contango Ore Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Calavo Growers Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, June 10, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
ProKidney Corp. Announces $125M Public Offeri...
Benzinga Newsdesk
ProKidney shares are trading lower after the ...
Benzinga Newsdesk
Jefferies Maintains Buy on ProKidney, Lowers ...
Benzinga Newsdesk
ProKidney Announces Operational Updates and P...
Benzinga Newsdesk
Wednesday, May 29, 2024
B of A Securities Maintains Neutral on ProKid...
Benzinga Newsdesk
Tuesday, May 14, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Shares of 'meme stocks' and high-short intere...
Benzinga Newsdesk
Friday, May 10, 2024
ProKidney Q1 EPS $(0.16) Remains Flat YoY, Ex...
Benzinga Newsdesk
Monday, April 22, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Wednesday, April 17, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, April 15, 2024
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Friday, March 22, 2024
Reported Late Thursday, ProKidney FY23 EPS $(...
Benzinga Newsdesk
Friday, March 08, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, March 07, 2024
Morgan Stanley Assumes ProKidney at Equal-Wei...
Benzinga Newsdesk
Wednesday, February 28, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Friday, February 16, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Tuesday, January 02, 2024
B of A Securities Downgrades ProKidney to Neu...
Benzinga Newsdesk
Wednesday, November 22, 2023
ProKidney Corp Files For Mixed Shelf Offering...
Benzinga Newsdesk
Monday, November 20, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
ProKidney shares are trading higher after the...
Benzinga Newsdesk
Prokidney Said On Nov 19, Co Entered Into Share Repurchase Agreement With SC Pipe Holdings And SC Master Holdings, To Repurchase 7.3M Class A Ordinary Shares At $1.309/Share
Charles Gross
Thursday, November 16, 2023
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Wednesday, November 15, 2023
ProKidney 10% Owner Trades Company's Stock
Benzinga Insights
Tuesday, November 14, 2023
ProKidney Q3 EPS $(0.18) Vs $(0.13) YoY, Cash...
Benzinga Newsdesk
Monday, November 13, 2023
ProKidney Announces Updated Positive Interim ...
Benzinga Newsdesk
Thursday, November 09, 2023
ProKidney Recent Insider Activity
Benzinga Insights
Wednesday, November 01, 2023
10% Owner At This Health Care Company Sells $645K of Stock
Benzinga Insights
Friday, October 27, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
ProKidney 10% Owner Trades Company's Stock
Benzinga Insights
Tuesday, October 24, 2023
10% Owner of ProKidney Makes $899K Sale
Benzinga Insights
Thursday, October 19, 2023
ProKidney 10% Owner Sold $1.21M In Company Stock
Benzinga Insights
Wednesday, October 11, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
10% Owner of ProKidney Sold $1.23M In Stock
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch